These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11515986

  • 1. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
    Cleophas TJ, van Ouwerkerk BM, van der Meulen J, Zwinderman AH.
    Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R, Marx A, Haller H.
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [Abstract] [Full Text] [Related]

  • 3. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
    Winer N, Folker A, Murphy JA, Hung E, Bard M, Perkelvald A, Sowers JR, Bakris GL.
    Prev Cardiol; 2005 Jan; 8(2):87-92. PubMed ID: 15860983
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF, Gerocarni B, Rosticci M, Borghi C.
    Clin Exp Hypertens; 2012 Jan; 34(2):113-7. PubMed ID: 21967031
    [Abstract] [Full Text] [Related]

  • 5. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
    De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Rosei CA, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Rosei EA.
    J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999
    [Abstract] [Full Text] [Related]

  • 6. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.
    Borghi C, Cicero AF.
    Clin Drug Investig; 2010 Mar; 30(12):843-54. PubMed ID: 20923243
    [Abstract] [Full Text] [Related]

  • 7. Replacement of angiotensin-converting enzyme inhibitors by angiotensin-II-receptor antagonists in hypertensive patients with type II diabetes mellitus: metabolic and hemodynamic consequences.
    van der Meulen J, Cleophas TJ, Zwinderman AH.
    Am J Ther; 1999 May; 6(3):123-7. PubMed ID: 10423654
    [Abstract] [Full Text] [Related]

  • 8. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
    Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT, Oakes R, Lukas MA, Anderson KM, Bell DS, GEMINI Investigators.
    JAMA; 2004 Nov 10; 292(18):2227-36. PubMed ID: 15536109
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
    Seravalle G, Brambilla G, Pizzalla DP, Casati A, Riva M, Cuspidi C, Bombelli M, Mancia G, Grassi G.
    J Am Soc Hypertens; 2016 Mar 10; 10(3):244-51. PubMed ID: 26831124
    [Abstract] [Full Text] [Related]

  • 10. Fixed-dose combination lercanidipine/enalapril.
    Hair PI, Scott LJ, Perry CM.
    Drugs; 2007 Mar 10; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC.
    Arzneimittelforschung; 2010 Mar 10; 60(3):124-30. PubMed ID: 20422943
    [Abstract] [Full Text] [Related]

  • 12. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
    Shigihara T, Sato A, Hayashi K, Saruta T.
    Hypertens Res; 2000 May 10; 23(3):219-26. PubMed ID: 10821130
    [Abstract] [Full Text] [Related]

  • 13. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
    De Ciuceis C, Salvetti M, Paini A, Rossini C, Muiesan ML, Duse S, Caletti S, Coschignano MA, Semeraro F, Trapletti V, Bertacchini F, Brami V, Petelca A, Agabiti Rosei E, Rizzoni D, Agabiti Rosei C.
    Intern Emerg Med; 2017 Oct 10; 12(7):963-974. PubMed ID: 28647890
    [Abstract] [Full Text] [Related]

  • 14. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M, Pruijm M, Wuerzner G.
    Expert Opin Drug Metab Toxicol; 2009 Aug 10; 5(8):981-7. PubMed ID: 19619074
    [Abstract] [Full Text] [Related]

  • 15. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G, Palano F, Pagannone E, Chin D, Ferrucci A, Volpe M.
    Expert Rev Cardiovasc Ther; 2009 Feb 10; 7(2):115-23. PubMed ID: 19210207
    [Abstract] [Full Text] [Related]

  • 16. [Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension].
    Gosteva EV, Vasil'eva LV.
    Kardiologiia; 2015 Feb 10; 55(2):32-6. PubMed ID: 26164986
    [Abstract] [Full Text] [Related]

  • 17. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG, Pontremoli R.
    J Nephrol; 2011 Feb 10; 24(4):428-37. PubMed ID: 21279953
    [Abstract] [Full Text] [Related]

  • 18. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ, van der Meulen J, van de Luit L, Zwinderman AH.
    Angiology; 1999 Oct 10; 50(10):797-803. PubMed ID: 10535718
    [Abstract] [Full Text] [Related]

  • 19. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C, Flati V, Rossini C, Rufo A, Porteri E, Di Gregorio J, Petroboni B, La Boria E, Donini C, Pasini E, Agabiti Rosei E, Rizzoni D.
    Blood Press; 2014 Dec 10; 23(6):330-8. PubMed ID: 24786779
    [Abstract] [Full Text] [Related]

  • 20. Lercanidipine: a review of its use in hypertension.
    McClellan KJ, Jarvis B.
    Drugs; 2000 Nov 10; 60(5):1123-40. PubMed ID: 11129125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.